Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank67
3Y CAGR-29.8%
5Y CAGR+2.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-29.8%/yr
Annual compound
5Y CAGR
+2.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 19.22% |
| 2024 | -15.24% |
| 2023 | 9.37% |
| 2022 | 55.48% |
| 2021 | 169.94% |
| 2020 | 16.78% |
| 2019 | 0.00% |